Transcription of API Synthesis and Formulation - baxterbiopharmasolutions.com
{{id}} {{{paragraph}}}
2009 Supplement to the September 2009 IssueAPI Synthesis and FormulationEUROPEDrug deliveryrug development is an arduous, financially risky pro-cess that has been estimated to cost pharmaceutical firms an average of $802 million for each therapeutic gaining marketing approval (1). To maximize return on the initial investment, companies look to strengthen their market position and extend product life cycles through reformulations, new routes of administration, and use of the latest technology. For injectable therapeutics, one way to accomplish this goal is to move a product s presentation from a vial to a prefilled sy-ringe. A prefilled syringe helps to increase dosing accuracy, con-venience, and safety; enhance patient quality of life; and reduce patient time in the clinic.
Drug delivery rug development is an arduous, financially risky pro-cess that has been estimated to cost pharmaceutical firms an average of $802 million for each therapeutic
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
FACTORS INFLUENCING CONTAINER TERMINALS, Stability Testing of Pharmaceutical Products, Factors influencing, Cyper TC Insecticide, PEST PRODUCTS, SPECIMEN LABEL Demon Max 1, SPECIMEN LABEL Demon® Max 1, Concrete properties at cryogenic temperatures, Herbicide, PULL HERE TO OPEN, CODE OF PRACTICE NITROGEN TRIFLUORIDE